Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk Related to Pre–Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction
Søren Lund Kristensen, David Preiss, Pardeep S. Jhund, et al.
Circulation Heart Failure (2016) Vol. 9, Iss. 1
Open Access | Times Cited: 339

Showing 26-50 of 339 citing articles:

Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes
Franco Cosmi, Li Shen, Michela Magnoli, et al.
European Journal of Heart Failure (2018) Vol. 20, Iss. 5, pp. 888-895
Open Access | Times Cited: 105
Prognostic Impact of Diabetes on Long-term Survival Outcomes in Patients With Heart Failure: A Meta-analysis
Marco Dauriz, Alessandro Mantovani, Stefano Bonapace, et al.
Diabetes Care (2017) Vol. 40, Iss. 11, pp. 1597-1605
Open Access | Times Cited: 97
Diabetic cardiomyopathy
Matthew M.Y. Lee, John J.V. McMurray, Ana Lorenzo-Almorós, et al.
Heart (2018) Vol. 105, Iss. 4, pp. 337-345
Open Access | Times Cited: 95
Heart Failure: The Most Important, Preventable, and Treatable Cardiovascular Complication of Type 2 Diabetes
Milton Packer
Diabetes Care (2017) Vol. 41, Iss. 1, pp. 11-13
Open Access | Times Cited: 92
Heart failure in type 2 diabetes: current perspectives on screening, diagnosis and management
Antonio Ceriello, Doina Catrinoiu, Chanchal Chandramouli, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 73
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence
Teresa Salvatore, Raffaele Galiero, Alfredo Caturano, et al.
Biomolecules (2021) Vol. 11, Iss. 12, pp. 1834-1834
Open Access | Times Cited: 73
Association between prediabetes and adverse outcomes in heart failure
Linlin Mai, Weixing Wen, Min Qiu, et al.
Diabetes Obesity and Metabolism (2021) Vol. 23, Iss. 11, pp. 2476-2483
Closed Access | Times Cited: 64
Diabetes and pre‐diabetes in patients with heart failure and preserved ejection fraction
Alice M. Jackson, Rasmus Rørth, Jiankang Liu, et al.
European Journal of Heart Failure (2021) Vol. 24, Iss. 3, pp. 497-509
Open Access | Times Cited: 58
Diabetes leading to heart failure and heart failure leading to diabetes: epidemiological and clinical evidence
Alberto Palazzuoli, Massimo Iacoviello
Heart Failure Reviews (2022) Vol. 28, Iss. 3, pp. 585-596
Open Access | Times Cited: 50
Metformin and the heart: Update on mechanisms of cardiovascular protection with special reference to comorbid type 2 diabetes and heart failure
Guntram Schernthaner, K. Brand, Clifford J. Bailey
Metabolism (2022) Vol. 130, pp. 155160-155160
Open Access | Times Cited: 41
Non‐cardiac comorbidities and intensive up‐titration of oral treatment in patients recently hospitalized for heart failure: Insights from the STRONG‐HF trial
Ovidiu Chioncel, Beth A. Davison, Marianna Adamo, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 11, pp. 1994-2006
Open Access | Times Cited: 22
Epidemiology of heart failure in diabetes: a disease in disguise
Anna G. Hoek, Elisa Dal Canto, Eva Wenker, et al.
Diabetologia (2024) Vol. 67, Iss. 4, pp. 574-601
Open Access | Times Cited: 15
Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases
Petar Seferović, Walter J. Paulus, Giuseppe Rosano, et al.
European Journal of Heart Failure (2024)
Closed Access | Times Cited: 9
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities
Simona Sacco, Matteo Foschi, Raffaele Ornello, et al.
Diabetologia (2024) Vol. 67, Iss. 7, pp. 1192-1205
Open Access | Times Cited: 8
Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease
Stella Bernardi, Andrea Michelli, Giulia Zuolo, et al.
Journal of Diabetes Research (2016) Vol. 2016, pp. 1-17
Open Access | Times Cited: 85
Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes
Søren Lund Kristensen, Pardeep S. Jhund, Matthew M.Y. Lee, et al.
Cardiovascular Drugs and Therapy (2017) Vol. 31, Iss. 5-6, pp. 545-549
Open Access | Times Cited: 79
Prognostic Impact of Diabetes and Prediabetes on Survival Outcomes in Patients With Chronic Heart Failure: A Post‐Hoc Analysis of the GISSI‐HF (Gruppo Italiano per lo Studio della Sopravvivenza nella Insufficienza Cardiaca‐Heart Failure) Trial
Marco Dauriz, Giovanni Targher, Pier Luigi Temporelli, et al.
Journal of the American Heart Association (2017) Vol. 6, Iss. 7
Open Access | Times Cited: 64
IgE Contributes to Atherosclerosis and Obesity by Affecting Macrophage Polarization, Macrophage Protein Network, and Foam Cell Formation
Xian Zhang, Jie Li, Songyuan Luo, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2020) Vol. 40, Iss. 3, pp. 597-610
Open Access | Times Cited: 62
Insulin treatment and clinical outcomes in patients with diabetes and heart failure with preserved ejection fraction
Li Shen, Rasmus Rørth, Deborah Cosmi, et al.
European Journal of Heart Failure (2019) Vol. 21, Iss. 8, pp. 974-984
Open Access | Times Cited: 61
SGLT2 inhibitors: the future for treatment of type 2 diabetes mellitus and other chronic diseases
Christoph Wanner, Nikolaus Marx
Diabetologia (2018) Vol. 61, Iss. 10, pp. 2134-2139
Open Access | Times Cited: 60
Neprilysin inhibition: a new therapeutic option for type 2 diabetes?
Nathalie Esser, Sakeneh Zraika
Diabetologia (2019) Vol. 62, Iss. 7, pp. 1113-1122
Open Access | Times Cited: 57
In-situ formable dextran/chitosan-based hydrogels functionalized with collagen and EGF for diabetic wounds healing
Ping Hu, Qiqi Lei, Shuxia Duan, et al.
Biomaterials Advances (2022) Vol. 136, pp. 212773-212773
Closed Access | Times Cited: 32
Research into the effect Of SGLT2 inhibition on left ventricular remodelling in patients with heart failure and diabetes mellitus (REFORM) trial rationale and design
Jagdeep Singh, Amir Fathi, Keeran Vickneson, et al.
Cardiovascular Diabetology (2016) Vol. 15, Iss. 1
Open Access | Times Cited: 59
Effect of glucose-lowering therapies on heart failure
Michael E. Nassif, Mikhail Kosiborod
Nature Reviews Cardiology (2018) Vol. 15, Iss. 5, pp. 282-291
Closed Access | Times Cited: 53
Telmisartan and thiorphan combination treatment attenuates fibrosis and apoptosis in preventing diabetic cardiomyopathy
Vajir Malek, Anil Bhanudas Gaikwad
Cardiovascular Research (2018) Vol. 115, Iss. 2, pp. 373-384
Open Access | Times Cited: 53

Scroll to top